Table III.
Immunohistochemical assessments of inflammation, proliferation and apoptosis in mammary tissue
Comparison | P value by likelihood ratio test | ||||
---|---|---|---|---|---|
pp65 | Ki67 | CCND1 | pH3 | Caspase 3 | |
i.duc void polymer versus i.duc NanoCurc | 0.0001 | 0.003 | 0.407 | <0.0001 | 0.880 |
i.duc void polymer versus i.duc free curcumin | 0.067 | 0.003 | 0.764 | 0.086 | <0.0001 |
i.duc void polymer versus oral free curcumin | 0.345 | 0.894 | 0.008 | 0.007 | <0.0001 |
i.duc NanoCurc versus i.duc free curcumin | 0.051 | >0.999 | 0.302 | 0.093 | 0.0004 |
i.duc NanoCurc versus oral free curcumin | 0.002 | 0.015 | 0.079 | <0.0001 | 0.004 |
i.duc free curcumin versus oral free curcumin | 0.339 | 0.015 | 0.005 | 0.002 | 0.127 |
Nuclear localization of pp65 (phospho p65), the principal subunit protein of NFκB and a marker of inflammation, and proliferation markers: Cyclin D1 (CCND1), phospho-histone H3 (pH3) and Ki67 was significantly decreased, whereas cleaved caspase 3, a marker of apoptosis, was significantly increased in several treatment comparisons.
To account for multiple testing, a significant difference is considered at P < 0.0083 based on Bonferroni adjustment.